PMC:7127067 / 8024-9271 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T10","span":{"begin":188,"end":193},"obj":"Body_part"},{"id":"T11","span":{"begin":324,"end":347},"obj":"Body_part"},{"id":"T12","span":{"begin":394,"end":400},"obj":"Body_part"},{"id":"T13","span":{"begin":445,"end":450},"obj":"Body_part"},{"id":"T14","span":{"begin":523,"end":545},"obj":"Body_part"},{"id":"T15","span":{"begin":844,"end":849},"obj":"Body_part"},{"id":"T16","span":{"begin":1088,"end":1093},"obj":"Body_part"}],"attributes":[{"id":"A10","pred":"fma_id","subj":"T10","obj":"http://purl.org/sig/ont/fma/fma9576"},{"id":"A11","pred":"fma_id","subj":"T11","obj":"http://purl.org/sig/ont/fma/fma45661"},{"id":"A12","pred":"fma_id","subj":"T12","obj":"http://purl.org/sig/ont/fma/fma228738"},{"id":"A13","pred":"fma_id","subj":"T13","obj":"http://purl.org/sig/ont/fma/fma9576"},{"id":"A14","pred":"fma_id","subj":"T14","obj":"http://purl.org/sig/ont/fma/fma7334"},{"id":"A15","pred":"fma_id","subj":"T15","obj":"http://purl.org/sig/ont/fma/fma12274"},{"id":"A16","pred":"fma_id","subj":"T16","obj":"http://purl.org/sig/ont/fma/fma12274"}],"text":"It is important to note that there are similarities in the symptoms between COVID-19 and earlier betacoronavirus such as fever, dry cough, dyspnea, and bilateral ground-glass opacities on chest CT scans [6]. However, COVID-19 showed some unique clinical features that include the targeting of the lower airway as evident by upper respiratory tract symptoms like rhinorrhoea, sneezing, and sore throat [15,16]. In addition, based on results from chest radiographs upon admission, some of the cases show an infiltrate in the upper lobe of the lung that is associated with increasing dyspnea with hypoxemia [17]. Importantly, whereas patients infected with COVID-19 developed gastrointestinal symptoms like diarrhoea, a low percentage of MERS-CoV or SARS-CoV patients experienced similar GI distress. Therefore, it is important to test faecal and urine samples to exclude a potential alternative route of transmission, specifically through health care workers, patients etc (Fig. 2) [15,16]. Therefore, development of methods to identify the various modes of transmission such as feacal and urine samples are urgently warranted in order to develop strategies to inhibit and/or minimize transmission and to develop therapeutics to control the disease."}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T8","span":{"begin":188,"end":193},"obj":"Body_part"},{"id":"T9","span":{"begin":324,"end":347},"obj":"Body_part"},{"id":"T10","span":{"begin":330,"end":347},"obj":"Body_part"},{"id":"T11","span":{"begin":394,"end":400},"obj":"Body_part"},{"id":"T12","span":{"begin":445,"end":450},"obj":"Body_part"},{"id":"T13","span":{"begin":523,"end":545},"obj":"Body_part"},{"id":"T14","span":{"begin":529,"end":533},"obj":"Body_part"},{"id":"T15","span":{"begin":541,"end":545},"obj":"Body_part"},{"id":"T16","span":{"begin":844,"end":849},"obj":"Body_part"},{"id":"T17","span":{"begin":1088,"end":1093},"obj":"Body_part"}],"attributes":[{"id":"A8","pred":"uberon_id","subj":"T8","obj":"http://purl.obolibrary.org/obo/UBERON_0001443"},{"id":"A9","pred":"uberon_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/UBERON_0001557"},{"id":"A10","pred":"uberon_id","subj":"T10","obj":"http://purl.obolibrary.org/obo/UBERON_0000065"},{"id":"A11","pred":"uberon_id","subj":"T11","obj":"http://purl.obolibrary.org/obo/UBERON_0000341"},{"id":"A12","pred":"uberon_id","subj":"T12","obj":"http://purl.obolibrary.org/obo/UBERON_0001443"},{"id":"A13","pred":"uberon_id","subj":"T13","obj":"http://purl.obolibrary.org/obo/UBERON_0008948"},{"id":"A14","pred":"uberon_id","subj":"T14","obj":"http://purl.obolibrary.org/obo/UBERON_3010752"},{"id":"A15","pred":"uberon_id","subj":"T15","obj":"http://purl.obolibrary.org/obo/UBERON_0002048"},{"id":"A16","pred":"uberon_id","subj":"T16","obj":"http://purl.obolibrary.org/obo/UBERON_0001088"},{"id":"A17","pred":"uberon_id","subj":"T17","obj":"http://purl.obolibrary.org/obo/UBERON_0001088"}],"text":"It is important to note that there are similarities in the symptoms between COVID-19 and earlier betacoronavirus such as fever, dry cough, dyspnea, and bilateral ground-glass opacities on chest CT scans [6]. However, COVID-19 showed some unique clinical features that include the targeting of the lower airway as evident by upper respiratory tract symptoms like rhinorrhoea, sneezing, and sore throat [15,16]. In addition, based on results from chest radiographs upon admission, some of the cases show an infiltrate in the upper lobe of the lung that is associated with increasing dyspnea with hypoxemia [17]. Importantly, whereas patients infected with COVID-19 developed gastrointestinal symptoms like diarrhoea, a low percentage of MERS-CoV or SARS-CoV patients experienced similar GI distress. Therefore, it is important to test faecal and urine samples to exclude a potential alternative route of transmission, specifically through health care workers, patients etc (Fig. 2) [15,16]. Therefore, development of methods to identify the various modes of transmission such as feacal and urine samples are urgently warranted in order to develop strategies to inhibit and/or minimize transmission and to develop therapeutics to control the disease."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T71","span":{"begin":76,"end":84},"obj":"Disease"},{"id":"T72","span":{"begin":217,"end":225},"obj":"Disease"},{"id":"T73","span":{"begin":389,"end":400},"obj":"Disease"},{"id":"T74","span":{"begin":654,"end":662},"obj":"Disease"},{"id":"T75","span":{"begin":704,"end":713},"obj":"Disease"},{"id":"T76","span":{"begin":747,"end":755},"obj":"Disease"},{"id":"T77","span":{"begin":747,"end":751},"obj":"Disease"}],"attributes":[{"id":"A71","pred":"mondo_id","subj":"T71","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A72","pred":"mondo_id","subj":"T72","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A73","pred":"mondo_id","subj":"T73","obj":"http://purl.obolibrary.org/obo/MONDO_0002258"},{"id":"A74","pred":"mondo_id","subj":"T74","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A75","pred":"mondo_id","subj":"T75","obj":"http://purl.obolibrary.org/obo/MONDO_0001673"},{"id":"A76","pred":"mondo_id","subj":"T76","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A77","pred":"mondo_id","subj":"T77","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"It is important to note that there are similarities in the symptoms between COVID-19 and earlier betacoronavirus such as fever, dry cough, dyspnea, and bilateral ground-glass opacities on chest CT scans [6]. However, COVID-19 showed some unique clinical features that include the targeting of the lower airway as evident by upper respiratory tract symptoms like rhinorrhoea, sneezing, and sore throat [15,16]. In addition, based on results from chest radiographs upon admission, some of the cases show an infiltrate in the upper lobe of the lung that is associated with increasing dyspnea with hypoxemia [17]. Importantly, whereas patients infected with COVID-19 developed gastrointestinal symptoms like diarrhoea, a low percentage of MERS-CoV or SARS-CoV patients experienced similar GI distress. Therefore, it is important to test faecal and urine samples to exclude a potential alternative route of transmission, specifically through health care workers, patients etc (Fig. 2) [15,16]. Therefore, development of methods to identify the various modes of transmission such as feacal and urine samples are urgently warranted in order to develop strategies to inhibit and/or minimize transmission and to develop therapeutics to control the disease."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T49","span":{"begin":188,"end":193},"obj":"http://www.ebi.ac.uk/efo/EFO_0000965"},{"id":"T50","span":{"begin":303,"end":312},"obj":"http://purl.obolibrary.org/obo/UBERON_0001005"},{"id":"T51","span":{"begin":445,"end":450},"obj":"http://www.ebi.ac.uk/efo/EFO_0000965"},{"id":"T52","span":{"begin":541,"end":545},"obj":"http://purl.obolibrary.org/obo/UBERON_0002048"},{"id":"T53","span":{"begin":541,"end":545},"obj":"http://www.ebi.ac.uk/efo/EFO_0000934"},{"id":"T54","span":{"begin":715,"end":716},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T55","span":{"begin":828,"end":832},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"},{"id":"T56","span":{"begin":869,"end":870},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"It is important to note that there are similarities in the symptoms between COVID-19 and earlier betacoronavirus such as fever, dry cough, dyspnea, and bilateral ground-glass opacities on chest CT scans [6]. However, COVID-19 showed some unique clinical features that include the targeting of the lower airway as evident by upper respiratory tract symptoms like rhinorrhoea, sneezing, and sore throat [15,16]. In addition, based on results from chest radiographs upon admission, some of the cases show an infiltrate in the upper lobe of the lung that is associated with increasing dyspnea with hypoxemia [17]. Importantly, whereas patients infected with COVID-19 developed gastrointestinal symptoms like diarrhoea, a low percentage of MERS-CoV or SARS-CoV patients experienced similar GI distress. Therefore, it is important to test faecal and urine samples to exclude a potential alternative route of transmission, specifically through health care workers, patients etc (Fig. 2) [15,16]. Therefore, development of methods to identify the various modes of transmission such as feacal and urine samples are urgently warranted in order to develop strategies to inhibit and/or minimize transmission and to develop therapeutics to control the disease."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T3","span":{"begin":785,"end":787},"obj":"Chemical"}],"attributes":[{"id":"A3","pred":"chebi_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/CHEBI_73907"}],"text":"It is important to note that there are similarities in the symptoms between COVID-19 and earlier betacoronavirus such as fever, dry cough, dyspnea, and bilateral ground-glass opacities on chest CT scans [6]. However, COVID-19 showed some unique clinical features that include the targeting of the lower airway as evident by upper respiratory tract symptoms like rhinorrhoea, sneezing, and sore throat [15,16]. In addition, based on results from chest radiographs upon admission, some of the cases show an infiltrate in the upper lobe of the lung that is associated with increasing dyspnea with hypoxemia [17]. Importantly, whereas patients infected with COVID-19 developed gastrointestinal symptoms like diarrhoea, a low percentage of MERS-CoV or SARS-CoV patients experienced similar GI distress. Therefore, it is important to test faecal and urine samples to exclude a potential alternative route of transmission, specifically through health care workers, patients etc (Fig. 2) [15,16]. Therefore, development of methods to identify the various modes of transmission such as feacal and urine samples are urgently warranted in order to develop strategies to inhibit and/or minimize transmission and to develop therapeutics to control the disease."}

{"project":"LitCovid-sentences","denotations":[{"id":"T60","span":{"begin":0,"end":207},"obj":"Sentence"},{"id":"T61","span":{"begin":208,"end":409},"obj":"Sentence"},{"id":"T62","span":{"begin":410,"end":609},"obj":"Sentence"},{"id":"T63","span":{"begin":610,"end":797},"obj":"Sentence"},{"id":"T64","span":{"begin":798,"end":988},"obj":"Sentence"},{"id":"T65","span":{"begin":989,"end":1247},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"It is important to note that there are similarities in the symptoms between COVID-19 and earlier betacoronavirus such as fever, dry cough, dyspnea, and bilateral ground-glass opacities on chest CT scans [6]. However, COVID-19 showed some unique clinical features that include the targeting of the lower airway as evident by upper respiratory tract symptoms like rhinorrhoea, sneezing, and sore throat [15,16]. In addition, based on results from chest radiographs upon admission, some of the cases show an infiltrate in the upper lobe of the lung that is associated with increasing dyspnea with hypoxemia [17]. Importantly, whereas patients infected with COVID-19 developed gastrointestinal symptoms like diarrhoea, a low percentage of MERS-CoV or SARS-CoV patients experienced similar GI distress. Therefore, it is important to test faecal and urine samples to exclude a potential alternative route of transmission, specifically through health care workers, patients etc (Fig. 2) [15,16]. Therefore, development of methods to identify the various modes of transmission such as feacal and urine samples are urgently warranted in order to develop strategies to inhibit and/or minimize transmission and to develop therapeutics to control the disease."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T22","span":{"begin":121,"end":126},"obj":"Phenotype"},{"id":"T23","span":{"begin":128,"end":137},"obj":"Phenotype"},{"id":"T24","span":{"begin":139,"end":146},"obj":"Phenotype"},{"id":"T25","span":{"begin":389,"end":400},"obj":"Phenotype"},{"id":"T26","span":{"begin":581,"end":588},"obj":"Phenotype"},{"id":"T27","span":{"begin":594,"end":603},"obj":"Phenotype"},{"id":"T28","span":{"begin":704,"end":713},"obj":"Phenotype"}],"attributes":[{"id":"A22","pred":"hp_id","subj":"T22","obj":"http://purl.obolibrary.org/obo/HP_0001945"},{"id":"A23","pred":"hp_id","subj":"T23","obj":"http://purl.obolibrary.org/obo/HP_0031246"},{"id":"A24","pred":"hp_id","subj":"T24","obj":"http://purl.obolibrary.org/obo/HP_0002094"},{"id":"A25","pred":"hp_id","subj":"T25","obj":"http://purl.obolibrary.org/obo/HP_0033050"},{"id":"A26","pred":"hp_id","subj":"T26","obj":"http://purl.obolibrary.org/obo/HP_0002094"},{"id":"A27","pred":"hp_id","subj":"T27","obj":"http://purl.obolibrary.org/obo/HP_0012418"},{"id":"A28","pred":"hp_id","subj":"T28","obj":"http://purl.obolibrary.org/obo/HP_0002014"}],"text":"It is important to note that there are similarities in the symptoms between COVID-19 and earlier betacoronavirus such as fever, dry cough, dyspnea, and bilateral ground-glass opacities on chest CT scans [6]. However, COVID-19 showed some unique clinical features that include the targeting of the lower airway as evident by upper respiratory tract symptoms like rhinorrhoea, sneezing, and sore throat [15,16]. In addition, based on results from chest radiographs upon admission, some of the cases show an infiltrate in the upper lobe of the lung that is associated with increasing dyspnea with hypoxemia [17]. Importantly, whereas patients infected with COVID-19 developed gastrointestinal symptoms like diarrhoea, a low percentage of MERS-CoV or SARS-CoV patients experienced similar GI distress. Therefore, it is important to test faecal and urine samples to exclude a potential alternative route of transmission, specifically through health care workers, patients etc (Fig. 2) [15,16]. Therefore, development of methods to identify the various modes of transmission such as feacal and urine samples are urgently warranted in order to develop strategies to inhibit and/or minimize transmission and to develop therapeutics to control the disease."}

{"project":"2_test","denotations":[{"id":"32113704-23891402-131566396","span":{"begin":402,"end":404},"obj":"23891402"},{"id":"32113704-23891402-131566396","span":{"begin":402,"end":404},"obj":"23891402"},{"id":"32113704-12682352-131566397","span":{"begin":405,"end":407},"obj":"12682352"},{"id":"32113704-12682352-131566397","span":{"begin":405,"end":407},"obj":"12682352"},{"id":"32113704-23891402-131566398","span":{"begin":981,"end":983},"obj":"23891402"},{"id":"32113704-23891402-131566398","span":{"begin":981,"end":983},"obj":"23891402"},{"id":"32113704-12682352-131566399","span":{"begin":984,"end":986},"obj":"12682352"},{"id":"32113704-12682352-131566399","span":{"begin":984,"end":986},"obj":"12682352"},{"id":"32113704-31986264-55638562","span":{"begin":204,"end":205},"obj":"31986264"},{"id":"32113704-31986264-55638562","span":{"begin":204,"end":205},"obj":"31986264"},{"id":"32113704-23891402-55638563","span":{"begin":402,"end":404},"obj":"23891402"},{"id":"32113704-23891402-55638563","span":{"begin":402,"end":404},"obj":"23891402"},{"id":"32113704-12682352-55638564","span":{"begin":405,"end":407},"obj":"12682352"},{"id":"32113704-12682352-55638564","span":{"begin":405,"end":407},"obj":"12682352"},{"id":"32113704-23891402-55638565","span":{"begin":981,"end":983},"obj":"23891402"},{"id":"32113704-23891402-55638565","span":{"begin":981,"end":983},"obj":"23891402"},{"id":"32113704-12682352-55638566","span":{"begin":984,"end":986},"obj":"12682352"},{"id":"32113704-12682352-55638566","span":{"begin":984,"end":986},"obj":"12682352"}],"text":"It is important to note that there are similarities in the symptoms between COVID-19 and earlier betacoronavirus such as fever, dry cough, dyspnea, and bilateral ground-glass opacities on chest CT scans [6]. However, COVID-19 showed some unique clinical features that include the targeting of the lower airway as evident by upper respiratory tract symptoms like rhinorrhoea, sneezing, and sore throat [15,16]. In addition, based on results from chest radiographs upon admission, some of the cases show an infiltrate in the upper lobe of the lung that is associated with increasing dyspnea with hypoxemia [17]. Importantly, whereas patients infected with COVID-19 developed gastrointestinal symptoms like diarrhoea, a low percentage of MERS-CoV or SARS-CoV patients experienced similar GI distress. Therefore, it is important to test faecal and urine samples to exclude a potential alternative route of transmission, specifically through health care workers, patients etc (Fig. 2) [15,16]. Therefore, development of methods to identify the various modes of transmission such as feacal and urine samples are urgently warranted in order to develop strategies to inhibit and/or minimize transmission and to develop therapeutics to control the disease."}

{"project":"LitCovid-PubTator","denotations":[{"id":"288","span":{"begin":97,"end":112},"obj":"Species"},{"id":"289","span":{"begin":631,"end":639},"obj":"Species"},{"id":"290","span":{"begin":735,"end":743},"obj":"Species"},{"id":"291","span":{"begin":747,"end":755},"obj":"Species"},{"id":"292","span":{"begin":756,"end":764},"obj":"Species"},{"id":"293","span":{"begin":958,"end":966},"obj":"Species"},{"id":"294","span":{"begin":76,"end":84},"obj":"Disease"},{"id":"295","span":{"begin":121,"end":126},"obj":"Disease"},{"id":"296","span":{"begin":128,"end":137},"obj":"Disease"},{"id":"297","span":{"begin":139,"end":146},"obj":"Disease"},{"id":"298","span":{"begin":217,"end":225},"obj":"Disease"},{"id":"299","span":{"begin":362,"end":373},"obj":"Disease"},{"id":"300","span":{"begin":389,"end":400},"obj":"Disease"},{"id":"301","span":{"begin":581,"end":588},"obj":"Disease"},{"id":"302","span":{"begin":594,"end":603},"obj":"Disease"},{"id":"303","span":{"begin":640,"end":648},"obj":"Disease"},{"id":"304","span":{"begin":654,"end":662},"obj":"Disease"},{"id":"305","span":{"begin":673,"end":698},"obj":"Disease"},{"id":"306","span":{"begin":704,"end":713},"obj":"Disease"},{"id":"307","span":{"begin":785,"end":796},"obj":"Disease"}],"attributes":[{"id":"A288","pred":"tao:has_database_id","subj":"288","obj":"Tax:694002"},{"id":"A289","pred":"tao:has_database_id","subj":"289","obj":"Tax:9606"},{"id":"A290","pred":"tao:has_database_id","subj":"290","obj":"Tax:1335626"},{"id":"A291","pred":"tao:has_database_id","subj":"291","obj":"Tax:694009"},{"id":"A292","pred":"tao:has_database_id","subj":"292","obj":"Tax:9606"},{"id":"A293","pred":"tao:has_database_id","subj":"293","obj":"Tax:9606"},{"id":"A294","pred":"tao:has_database_id","subj":"294","obj":"MESH:C000657245"},{"id":"A295","pred":"tao:has_database_id","subj":"295","obj":"MESH:D005334"},{"id":"A296","pred":"tao:has_database_id","subj":"296","obj":"MESH:D003371"},{"id":"A297","pred":"tao:has_database_id","subj":"297","obj":"MESH:D004417"},{"id":"A298","pred":"tao:has_database_id","subj":"298","obj":"MESH:C000657245"},{"id":"A300","pred":"tao:has_database_id","subj":"300","obj":"MESH:D010608"},{"id":"A301","pred":"tao:has_database_id","subj":"301","obj":"MESH:D004417"},{"id":"A302","pred":"tao:has_database_id","subj":"302","obj":"MESH:D000860"},{"id":"A303","pred":"tao:has_database_id","subj":"303","obj":"MESH:D007239"},{"id":"A304","pred":"tao:has_database_id","subj":"304","obj":"MESH:C000657245"},{"id":"A305","pred":"tao:has_database_id","subj":"305","obj":"MESH:D012817"},{"id":"A306","pred":"tao:has_database_id","subj":"306","obj":"MESH:D003967"},{"id":"A307","pred":"tao:has_database_id","subj":"307","obj":"MESH:D012128"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"It is important to note that there are similarities in the symptoms between COVID-19 and earlier betacoronavirus such as fever, dry cough, dyspnea, and bilateral ground-glass opacities on chest CT scans [6]. However, COVID-19 showed some unique clinical features that include the targeting of the lower airway as evident by upper respiratory tract symptoms like rhinorrhoea, sneezing, and sore throat [15,16]. In addition, based on results from chest radiographs upon admission, some of the cases show an infiltrate in the upper lobe of the lung that is associated with increasing dyspnea with hypoxemia [17]. Importantly, whereas patients infected with COVID-19 developed gastrointestinal symptoms like diarrhoea, a low percentage of MERS-CoV or SARS-CoV patients experienced similar GI distress. Therefore, it is important to test faecal and urine samples to exclude a potential alternative route of transmission, specifically through health care workers, patients etc (Fig. 2) [15,16]. Therefore, development of methods to identify the various modes of transmission such as feacal and urine samples are urgently warranted in order to develop strategies to inhibit and/or minimize transmission and to develop therapeutics to control the disease."}